Cited by 79Ovarian function and disordersSexual Differentiation and DisordersAdrenal Hormones and Disorders

Genes and proteins of the alternative steroid backdoor pathway for dihydrotestosterone synthesis are expressed in the human ovary and seem enhanced in the polycystic ovary syndrome

Open access
Marti, Nesa, Galván, José A., Pandey, Amit V., Trippel, Mafalda, Tapia, Coya, Müller, Michel, Perren, Aurel, Flück, Christa E.·2017·Molecular and Cellular Endocrinology

Abstract

Recently, dihydrotestosterone biosynthesis through the backdoor pathway has been implicated for the human testis in addition to the classic pathway for testosterone (T) synthesis. In the human ovary, androgen precursors are crucial for estrogen synthesis and hyperandrogenism in pathologies such as the polycystic ovary syndrome is partially due to ovarian overproduction. However, a role for the backdoor pathway is only established for the testis and the adrenal, but not for the human ovary. To investigate whether the backdoor pathway exists in normal and PCOS ovaries, we performed specific gene and protein expression studies on ovarian tissues. We found aldo-keto reductases (AKR1C1-1C4), 5α-reductases (SRD5A1/2) and retinol dehydrogenase (RoDH) expressed in the human ovary, indicating that the ovary might produce dihydrotestosterone via the backdoor pathway. Immunohistochemical studies showed specific localization of these proteins to the theca cells. PCOS ovaries show enhanced expression, what may account for the hyperandrogenism.

Integrity signals

Registry

Crossref · 10.1016/j.mce.2016.07.029

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The presence of SRD5A1, AKR1C2, AKR1C4 and HSD17B6 has been demonstrated for ovarian theca cells and some of those are required for the functioning of the backdoor pathway, which produces DHT by-passing DHEA, A4 and T.

    “The presence of steroid 5α-reductase type 1 (SRD5A1), aldo-keto reductase 1C2 (AKR1C2), aldo-keto reductase 1C4 (AKR1C4) and 17β-hydroxysteroid dehydrogenase type 6 (HSD17B6) has also been demonstrated for ovarian theca cells and some of those are required for the functioning of the backdoor pathway, which produces DHT by-passing DHEA, A4 and T, (section 5.3), (Marti et al., 2017).”

    From Intracrine androgen biosynthesis, metabolism and action revisited (2018) · cites this paper as Marti et al., 2017

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Marti, N., Galván, J. A., Pandey, A. V., Trippel, M., Tapia, C., Müller, M., Perren, A., & Flück, C. E.
Affiliations
University of Bern (CH)
Corresponding author
Flück, Christa E.
Venue
Molecular and Cellular Endocrinology
Publisher
Elsevier BV
Published
2017-02
Volume
441
Pages
116-123
ISSN
0303-7207 (ISSN-L)
OpenAlex
W2493373567
Cited by
76
References
26
Citations by year
2026: 6 · 2025: 4 · 2024: 7 · 2023: 12 · 2022: 6 · 2021: 3 · 2020: 9 · 2019: 12 · 2018: 4 · 2017: 11 · 2016: 2
FWCI
12.85
Type
journal article
Language
en
Open access
Locations
  • Molecular and Cellular Endocrinology (acceptedVersion)
  • PubMed (publishedVersion)
  • Bern Open Repository and Information System (University of Bern) (submittedVersion)
Funders
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (320030-146127)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sexual Differentiation and Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords
polycystic ovary syndrome, human ovary, aldo-keto reductase, 5α-reductase, retinol dehydrogenase, theca cells, ovarian hyperandrogenism, androgen precursors
MeSH terms
Adolescent, Adrenal Glands, Adult, Child, Female, Gene Expression Regulation, Humans, Male, Middle Aged, Ovary, Polycystic Ovary Syndrome, Dihydrotestosterone, Testis, Biosynthetic Pathways, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review